A curated listing of global health funding opportunities.
About
At the General Assembly, hosted by WHO in Geneva 3 to 4 December, the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) coalition of research funders launched a new funding mechanism, "Global Research Improving Pandemic Preparedness (GRIPP)". This initiative aims to improve collaboration between international research funders around the world, improving our research responses to future outbreaks, epidemics and wider health emergencies.
The first GRIPP call, focused on strengthening the clinical research ecosystem in LMICs to improve clinical trial good practices aligned with WHO guidance and GloPID-R Roadmap for Clinical Trial Coordination, will be launched in early 2025.
The International Science Partnerships Fund (ISPF) Research Collaboration Grants is offering seed funding for UK institutions to develop international partnerships focused on the major themes of our time: planet, health, technology, and talent. The participating countries are Indonesia, Jordan, Malaysia, South Africa, Thailand, and Turkey.
These collaborations should work with non-academic organisations and individuals to support the exchange of research and innovation expertise and the translation of research knowledge into tangible benefits.
- Expression of Interest (EOI): Only applicants who submit an EOI by 30 June will be eligible to proceed to the full application stage.
- Deadline for submission of full application: 4 August 2025
- Total award: £1.9 million is available for UK institutions to support up to 24 bilateral projects across 6 countries/territories.
- Deadline: 30 June 2025
The Global Health Innovative Technology (GHIT) Fund announces Request for Proposals (RFP) for the screening of compound libraries for the identification of novel compounds for malaria, tuberculosis, Chagas disease and leishmaniasis. The goal is to leverage the active screening programs of established Product Development Partnerships (PDP) and the relevant compound libraries from Japanese companies or academic institutions.
Possible collaborations should include one of the following three drug development PDPs: Medicines for Malaria Venture (MMV), Drugs for Neglected Diseases initiative (DNDi), and TB Alliance.
Interested applicants can find detailed information on the RFP on their website. Full applications are due 10:00 am (JST) 4 July 2025 .
About
Apply for funding to generate critical data that builds confidence in developing a new or repurposed medicine, medical device, diagnostic test, or other medical intervention.
The concept for the product should be backed by prior funding. Projects should focus on one high-risk step, not multiple, to ensure efficient management. This step must address the crucial missing evidence needed to rapidly de-risk onward development or determine failure. All human diseases and medical interventions are eligible for support, including in addressing global health issues.
criteria
- Award range: £50,000 - £300,000
- Deadline: 22 June 2025
- Duration: Between six and 18 months
- Publication date: 22 April 2025
- Eligibility: you must be based at a research organisation eligible for Medical Research Council (MRC) funding
Apply for the MRC Gap fund for early-stage development of new healthcare interventions
The GHIT Fund has announced the RFP for the development of new medicines, vaccines, and diagnostics for infectious diseases. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects may focus on R&D activities in the development stages: lead optimization, preclinical development, clinical development; parallel or concurrent development of multiple interventions; and activities to support licensure and WHO prequalification.
- Intent to Apply: 9 July 2025; 10:00 am JST
- Full proposal due: 7 August 2025; 10:00 am JST
- Maximum award: not specified
- Duration of project: maximum 2 years
ABOUT
The Medical Research Future Fund (MRFF) Australia, the National Health and Medical Research Council (NHMRC) Australia and National Institute for Health and Care Research (NIHR) UK are inviting applications for ambitious platform studies in areas of unmet medical need. The platform must be internationally collaborative, with joint leads based in Australia and the United Kingdom.
Applications to this funding opportunity must describe a platform trial seeking to evaluate a number of specified technologies. Each technology must have sufficient clinical, human proof of concept to justify a definitive efficacy study. This call is for either Phase 2 or Phase 3 focused platforms, where there is a pipeline of technologies which justifies a platform approach. This call will not support funding for studies aiming to run platforms seamlessly from phase 2 into phase 3. See call specifications for more details.
The funder is holding a webinar (1.5hrs) to support applicants to this funding opportunity on 19 November 2024, 08:00 UK (UTC+0)/19:00 AEDT (UTC+11). To register for the webinar, please sign up via their online form.
Amount: Aiming to fund 1 to 3 platforms for up to 7 Years. NHMRC and MRFF will fund the Australian research component and the NIHR will fund the UK research component of successful applications.
Learn more about the NIHR: Australia-UK platform studies in areas of unmet clinical need
About
The British Academy is inviting proposals for the next round of its International Interdisciplinary Research programme. Projects will be led by UK-based researchers in the humanities and social sciences working with international partners and wishing to develop interdisciplinary projects that range across all SHAPE and STEM disciplines on the theme of Transnational and Planetary Challenges.
The Academy will only accept applications that focus on one or more of transnational and planetary challenge domains - including on Global health, particularly the rising threat posed by pandemic disease and the linkages among human, animal, and environmental health (“One Health”). Other areas include earth system governance, digital and other transformative technologies, and outer space governance.
ELIGIBILITY
Early-career, Established researcher, Mid-career, Postdoctoral or equivalent research, Senior researcher
Amount
The total funding per award is up to £300,000 over 2 years.
Deadline
17 September 2025; 17:00 British Summer Time (BST)
The Writing Workshops seek to cultivate professional networks and mentorship and provide access for early-career researchers in developing countries to the academic requirements of journals, and to equip them with the necessary knowledge and skills to publish in these journals. The British Academy is inviting proposals for Writing Workshops in Brazil, Egypt, Indonesia, Jordan, Kenya, Malaysia, Philippines, South Africa, Turkey, Thailand, Vietnam and/or Least Developed Countries.
- Maximum award: £30,000.
- Criteria: Funding must be used in the direct delivery of the workshops, and can cover travel and related expenses.
- Award length: 2 years
- Deadline: 17 September 2025, 17:00 UK time